MICHELLE WILLIAMS: Open Payments
NPI 1639407018 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 83 payments from 19 companies in 2025. Trend: 2023 $2,570 · 2024 $2,456 · 2025 $1,680
Food & beverage: $1,594Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $220 |
| Galderma Laboratories, L.P. | 7 | $204 |
| Janssen Biotech, Inc. | 11 | $191 |
| Regeneron Healthcare Solutions, Inc. | 4 | $169 |
| GENZYME CORPORATION | 7 | $159 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Incyte Corporation | 5 | $119 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $83 |
| UCB, Inc. | 4 | $82 |
| LEO Pharma Inc. | 2 | $51 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, OPZELURA, COSENTYX, ILUMYA, Bimzelx.
Industry payments across PA — which companies pay providers there.
